BioAegis Therapeutics Announces Appointment of Two New Corporate Board Members
17 févr. 2022 17h42 HE
|
BioAegis Therapeutics
NORTH BRUNSWICK, N.J., Feb. 17, 2022 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage, private company developing therapies for inflammatory, infectious, and degenerative diseases...
Global Healthcare Gamification Market Envisioned to Generate a Revenue of $47,281.5 Million by 2026 and Grow at a CAGR of 11.9% over the Estimated Timeframe from 2019-2026 [120-Pages] | Confirmed by Research Dive
03 janv. 2022 09h00 HE
|
Research Dive
New York, USA, Jan. 03, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global healthcare gamification market is anticipated to generate a revenue of $47,281.5...
Global Healthcare Gamification Market Estimated to Surpass $47,281.5 Million by 2026, and Grow at a CAGR of 11.9% during the Forecast Period [120-Pages] | Divulge by Research Dive
21 déc. 2021 09h00 HE
|
Research Dive
New York, USA, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Research Dive states that the global healthcare gamification market is estimated to garner a revenue of $47,281.5 million by 2026, and rise at a CAGR...
Oral Contraceptive Pills Market Report Up to 2031: Visiongain Research Inc
08 déc. 2021 09h30 HE
|
Visiongain Ltd
Visiongain has published a new report on Oral Contraceptive Pills Market Report 2021-2031: Forecasts By Type (Combination, Progestin Only, and Others), By Age (15-19, 20-29, 30-39, and 40-49), By Drug...
Report from Incubate Policy Lab and Charles River Associates Finds Price Controls Would Decrease Investment in Critical Therapeutic Areas
18 nov. 2021 17h08 HE
|
Incubate
Washington, D.C., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Today, Incubate Policy Lab and Charles River Associates published a report detailing how investment into therapies for rare diseases and oncology...
Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal
28 oct. 2021 08h30 HE
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based biopharmaceutical enterprise, today announced...
Exavir Therapeutics announces publication of preclinical data for novel tenofovir prodrug, XVIR-210, in Nature Communications, demonstrating long-acting exposures sufficient for antiviral activity against HIV and HBV
16 sept. 2021 07h30 HE
|
Exavir Therapeutics
With a single administration, XVIR-210, a nano-formulated prodrug of tenofovir, provided drug levels sufficient for chronic HBV treatment, HIV treatment, and HIV prophylaxis for over two months in...
Global Healthcare Gamification Market Projected to Garner $47,281.5 Million Revenue by 2026, and Rise at a CAGR of 11.9% from 2019 to 2026 - Exclusive Report [120-Pages] by Research Dive
08 sept. 2021 09h00 HE
|
Research Dive
New York, USA, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Research Dive states that the global healthcare gamification market is anticipated to register a revenue of $47,281.5 million by 2026, at a CAGR of...
Salarius Pharmaceuticals to Report Second Quarter 2021 Financial Results
29 juil. 2021 07h33 HE
|
Salarius Pharmaceuticals, Inc.
HOUSTON, July 29, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas,...
Global Healthcare Gamification Market Estimated to Hit $47,281.5 Million and Grow with a Significant CAGR of 11.9% from 2019 to 2026 – Exclusive Report [120 Pages] By Research Dive
29 juin 2021 09h00 HE
|
Research Dive
New York, USA, June 29, 2021 (GLOBE NEWSWIRE) -- A latest report on the global healthcare gamification market has been added by Research Dive to its offerings. As per the report, the market is...